President

Shalini Singh, MD (Roche Diagnostics Solutions) Dr. Shalini Singh is a pathologist and is Head of Pathology at Roche Tissue Diagnostics in Tucson, AZ. She has been with Roche for 13 years. Her primary interests include Digital pathology, personalized healthcare, molecular pathology, translational oncology, and immunotherapy. She is licensed physician with expertise in molecular and genetic pathology and companion diagnostics. She is a Fellow of the College of American Pathologists and collaborates with CAP foundation Educational Grant for residents’ rotation at Roche Tissue Diagnostics. She is an expert in strategic partnerships between Pharma and Diagnostics collaboration.

President-Elect

David Ferber, MD (Leica Biosystems) Dr. David Ferber is a pathologist and Senior Medical and Scientific Affairs liaison at Leica Biosystems. He has greater than 20 years of experience in anatomic and clinical practice with special interest/expertise in genitourinary pathology. He has held many roles during his clinical career including director of the autopsy service, supervisor of pathology assistants, transitional resident faculty, pathology representative on Cancer Committee, and member of virtual tumor board project. He is a graduate of University of Wisconsin School of Medicine and Public Health and completed residency at Medical College of Wisconsin. He is a fellow of the College of American Pathologists and member of the Digital Pathology Society. He is a licensed physician particularly interested in digital pathology and innovation eager to take on the challenges of his role as medical science liaison.

Treasurer & Immediate Past President

Erico von Bueren, MD, PhD, MOR (Sakura Finetek USA, Inc.) Dr. Erico von Bueren is the Senior Director of Marketing and Strategy for Sakura Finetek USA, Inc. After his study and Doctorate in Medicine (Milano, Essen, Bochum, Frankfurt, Universities in Italy and Germany) and Masters in Operations Research (Aachen, Germany), Mr. von Bueren started his career in the pharmaceutical industry in medical, product and marketing management in several therapeutic areas (Ferring Pharmaceuticals and Schwarz Pharma/UCB). After 10 years, he switched to the in-vitro diagnostic industry concentrating on the fields of flow cytometry and anatomic pathology (Dako/Agilent, Denmark and U.S.A., and Thermo Fisher Scientific, U.S.A.). Now at Sakura Finetek USA, his focus in commercial and global product and market development resides in automating and standardizing anatomic pathology through continuous innovation.

Benefactor Director

Joshua Greenlee, MBA, IASSC CBB™, HT/HTL(ASCP)^cm (Sakura Finetek USA, Inc.) Joshua Greenlee is a Senior Product Manager & Laboratory Workflow/Productivity Strategist for Sakura Finetek USA, Inc. He has greater than 20 years of laboratory experience, primarily in anatomic pathology. He holds a Bachelor of Science in Biology, Master of Business Administration specializing in Project Management, and is dual ASCP certified as an HT/HTL(ASCP)cm. In addition to laboratory work, he spent 4 years working in the NAACLS accredited histology program at Phoenix College. He joined Sakura Finetek USA, Inc., in 2015. With his current position, as an IASSC Certified Black Belt in Lean Six Sigma, Joshua focuses on workflow and implementation of innovative automation solutions in anatomic pathology.

Benefactor Director

Fangru Lian, MD (Leica Biosystems) Dr. Fangru Lian is a pathologist and Senior Medical Director at Leica Biosystems. She has greater than 20 years of experience in dermatopathology, anatomic and clinical pathology in academic and diagnostic industry. Her primary interests include companion diagnostics, digital pathology, immunotherapy, and multiplexing development. She is a Fellow of the College of American Pathologists and member of the Digital Pathology Society. She is an expert in dermatopathology, digital pathology and companion diagnostics.

Benefactor Director

Dionne Roberge, PMP, HT (ASCP) ^cm (Roche Diagnostic Solutions) Dionne has over 30 years of industry experience in the anatomic pathology market, as a laboratorian, technical support representative, sales representative, sales and marketing manager, project manager and an experienced project leader. She started her career at the University of Connecticut where she practiced histotechnology for 15 years. She has a Bachelor of Science in Business Management, a Master of Science in Organizational Leadership and is a board certified Project Manager. Today she leads on market and development teams and has experience in companion diagnostic and system automation development at Roche Tissue Diagnostics located in Tucson, AZ.